1. Home
  2. DRUG vs FSFG Comparison

DRUG vs FSFG Comparison

Compare DRUG & FSFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRUG
  • FSFG
  • Stock Information
  • Founded
  • DRUG 2019
  • FSFG 2008
  • Country
  • DRUG United States
  • FSFG United States
  • Employees
  • DRUG N/A
  • FSFG N/A
  • Industry
  • DRUG Pharmaceuticals and Biotechnology
  • FSFG Savings Institutions
  • Sector
  • DRUG Health Care
  • FSFG Finance
  • Exchange
  • DRUG Nasdaq
  • FSFG Nasdaq
  • Market Cap
  • DRUG 199.7M
  • FSFG 177.8M
  • IPO Year
  • DRUG N/A
  • FSFG 2008
  • Fundamental
  • Price
  • DRUG $43.96
  • FSFG $27.64
  • Analyst Decision
  • DRUG Strong Buy
  • FSFG Strong Buy
  • Analyst Count
  • DRUG 8
  • FSFG 3
  • Target Price
  • DRUG $83.60
  • FSFG $31.50
  • AVG Volume (30 Days)
  • DRUG 53.0K
  • FSFG 18.0K
  • Earning Date
  • DRUG 08-11-2025
  • FSFG 10-23-2025
  • Dividend Yield
  • DRUG N/A
  • FSFG 2.44%
  • EPS Growth
  • DRUG N/A
  • FSFG 130.94
  • EPS
  • DRUG N/A
  • FSFG 3.10
  • Revenue
  • DRUG N/A
  • FSFG $79,674,000.00
  • Revenue This Year
  • DRUG N/A
  • FSFG $0.16
  • Revenue Next Year
  • DRUG N/A
  • FSFG $8.49
  • P/E Ratio
  • DRUG N/A
  • FSFG $8.91
  • Revenue Growth
  • DRUG N/A
  • FSFG 10.53
  • 52 Week Low
  • DRUG $0.94
  • FSFG $21.63
  • 52 Week High
  • DRUG $79.02
  • FSFG $30.94
  • Technical
  • Relative Strength Index (RSI)
  • DRUG 69.20
  • FSFG 64.06
  • Support Level
  • DRUG $34.19
  • FSFG $26.22
  • Resistance Level
  • DRUG $46.13
  • FSFG $26.97
  • Average True Range (ATR)
  • DRUG 3.38
  • FSFG 0.62
  • MACD
  • DRUG 0.26
  • FSFG 0.10
  • Stochastic Oscillator
  • DRUG 82.17
  • FSFG 95.71

About DRUG Bright Minds Biosciences Inc.

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

About FSFG First Savings Financial Group Inc.

First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.

Share on Social Networks: